BRADFORD CRUTCHFIELD Insider Trading $TXG 10x Genomics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRADFORD CRUTCHFIELD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRADFORD CRUTCHFIELD. BRADFORD CRUTCHFIELD is Vice President in BIO RAD LABORATORIES INC ($BIO) and Chief Commercial Officer in 10x Genomics, Inc. ($TXG).
BRADFORD CRUTCHFIELD in 10x Genomics, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of BRADFORD CRUTCHFIELD: Chief Commercial Officer
Holdings: 51,608 shares
Latest Transaction: May 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BRADFORD CRUTCHFIELD in 10x Genomics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 545,000 | |
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 137.57 | 100 | 13,757 | 34,608 | 34.7 K to 34.6 K (-0.29 %) |
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 136.80 | 1,200 | 164,164 | 34,708 | 35.9 K to 34.7 K (-3.34 %) |
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 135.74 | 2,702 | 366,781 | 35,908 | 38.6 K to 35.9 K (-7.00 %) |
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 134.70 | 7,875 | 1,060,759 | 38,610 | 46.5 K to 38.6 K (-16.94 %) |
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 133.86 | 5,123 | 685,759 | 46,485 | 51.6 K to 46.5 K (-9.93 %) |
| May 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 562,000 | |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 192.17 | 300 | 57,652 | 34,608 | 34.9 K to 34.6 K (-0.86 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 190.31 | 1,100 | 209,340 | 34,908 | 36 K to 34.9 K (-3.05 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 189.34 | 1,400 | 265,075 | 36,008 | 37.4 K to 36 K (-3.74 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 188.36 | 2,398 | 451,695 | 37,408 | 39.8 K to 37.4 K (-6.02 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 187.10 | 1,996 | 373,450 | 39,806 | 41.8 K to 39.8 K (-4.77 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 186.31 | 2,855 | 531,911 | 41,802 | 44.7 K to 41.8 K (-6.39 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 185.14 | 1,500 | 277,714 | 44,657 | 46.2 K to 44.7 K (-3.25 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 184.32 | 600 | 110,591 | 46,157 | 46.8 K to 46.2 K (-1.28 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 182.75 | 1,302 | 237,938 | 46,757 | 48.1 K to 46.8 K (-2.71 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 181.84 | 2,642 | 480,426 | 48,059 | 50.7 K to 48.1 K (-5.21 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 181.10 | 907 | 164,260 | 50,701 | 51.6 K to 50.7 K (-1.76 %) |
| Apr 13 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 579,000 | |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 159.51 | 2,100 | 334,977 | 34,608 | 36.7 K to 34.6 K (-5.72 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 158.85 | 3,176 | 504,513 | 36,708 | 39.9 K to 36.7 K (-7.96 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 157.70 | 2,211 | 348,684 | 39,884 | 42.1 K to 39.9 K (-5.25 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 156.52 | 3,606 | 564,404 | 42,095 | 45.7 K to 42.1 K (-7.89 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 155.54 | 3,807 | 592,148 | 45,701 | 49.5 K to 45.7 K (-7.69 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 154.52 | 2,100 | 324,492 | 49,508 | 51.6 K to 49.5 K (-4.07 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 579,000 | |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 159.51 | 2,100 | 334,977 | 34,608 | 36.7 K to 34.6 K (-5.72 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 158.85 | 3,176 | 504,513 | 36,708 | 39.9 K to 36.7 K (-7.96 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 157.70 | 2,211 | 348,684 | 39,884 | 42.1 K to 39.9 K (-5.25 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 156.52 | 3,606 | 564,404 | 42,095 | 45.7 K to 42.1 K (-7.89 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 155.54 | 3,807 | 592,148 | 45,701 | 49.5 K to 45.7 K (-7.69 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 154.52 | 2,100 | 324,492 | 49,508 | 51.6 K to 49.5 K (-4.07 %) |
| Mar 16 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 596,000 | |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 178.92 | 200 | 35,783 | 34,608 | 34.8 K to 34.6 K (-0.57 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 177.86 | 900 | 160,073 | 34,808 | 35.7 K to 34.8 K (-2.52 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 176.95 | 2,700 | 477,751 | 35,708 | 38.4 K to 35.7 K (-7.03 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 175.94 | 8,451 | 1,486,839 | 38,408 | 46.9 K to 38.4 K (-18.03 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 175.25 | 4,003 | 701,522 | 46,859 | 50.9 K to 46.9 K (-7.87 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 173.99 | 746 | 129,796 | 50,862 | 51.6 K to 50.9 K (-1.45 %) |
| Feb 03 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 613,000 | |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 141.77 | 400 | 56,708 | 34,608 | 35 K to 34.6 K (-1.14 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 140.74 | 3,135 | 441,211 | 35,008 | 38.1 K to 35 K (-8.22 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 139.89 | 10,465 | 1,463,947 | 38,143 | 48.6 K to 38.1 K (-21.53 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 138.97 | 3,000 | 416,908 | 48,608 | 51.6 K to 48.6 K (-5.81 %) |
| Jan 06 2021 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 51,608 | 34.6 K to 51.6 K (+49.12 %) |
| Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 5.04 | 13,333 | 67,198 | 111,667 | |
| Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.20 | 20,312 | 24,374 | 4,688 | |
| Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 5.04 | 13,333 | 67,198 | 34,608 | 21.3 K to 34.6 K (+62.67 %) |
| Dec 30 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.20 | 20,312 | 24,374 | 21,275 | 963 to 21.3 K (+2,109.24 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 6,496 | 7,535 | 647,000 | |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 10,504 | 12,185 | 653,496 | |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 138.43 | 200 | 27,686 | 963 | 1.2 K to 963 (-17.20 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 137.56 | 3,898 | 536,203 | 1,163 | 5.1 K to 1.2 K (-77.02 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 136.60 | 2,198 | 300,255 | 5,061 | 7.3 K to 5.1 K (-30.28 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 135.42 | 200 | 27,084 | 7,259 | 7.5 K to 7.3 K (-2.68 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 6,496 | 7,535 | 7,459 | 963 to 7.5 K (+674.56 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 139.25 | 400 | 55,698 | 963 | 1.4 K to 963 (-29.35 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 138.40 | 800 | 110,719 | 1,363 | 2.2 K to 1.4 K (-36.99 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 136.97 | 1,200 | 164,361 | 2,163 | 3.4 K to 2.2 K (-35.68 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 136.07 | 6,604 | 898,572 | 3,363 | 10 K to 3.4 K (-66.26 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 135.29 | 1,500 | 202,938 | 9,967 | 11.5 K to 10 K (-13.08 %) |
| Nov 04 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 10,504 | 12,185 | 11,467 | 963 to 11.5 K (+1,090.76 %) |
| Oct 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 664,000 | |
| Oct 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 126.88 | 300 | 38,064 | 963 | 1.3 K to 963 (-23.75 %) |
| Oct 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 125.99 | 3,475 | 437,822 | 1,263 | 4.7 K to 1.3 K (-73.34 %) |
| Oct 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 125.48 | 10,725 | 1,345,731 | 4,738 | 15.5 K to 4.7 K (-69.36 %) |
| Oct 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 124.26 | 2,500 | 310,643 | 15,463 | 18 K to 15.5 K (-13.92 %) |
| Oct 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,963 | 963 to 18 K (+1,765.32 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 3,224 | 3,740 | 681,000 | |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 13,776 | 15,980 | 684,224 | |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 114.89 | 50 | 5,745 | 963 | 1 K to 963 (-4.94 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 114.10 | 150 | 17,115 | 1,013 | 1.2 K to 1 K (-12.90 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 113.18 | 528 | 59,759 | 1,163 | 1.7 K to 1.2 K (-31.22 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 112.32 | 1,496 | 168,035 | 1,691 | 3.2 K to 1.7 K (-46.94 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 111.33 | 1,000 | 111,327 | 3,187 | 4.2 K to 3.2 K (-23.88 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 3,224 | 3,740 | 4,187 | 963 to 4.2 K (+334.79 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 115.41 | 500 | 57,704 | 963 | 1.5 K to 963 (-34.18 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 114.65 | 4,789 | 549,039 | 1,463 | 6.3 K to 1.5 K (-76.60 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 113.82 | 5,887 | 670,067 | 6,252 | 12.1 K to 6.3 K (-48.50 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 112.92 | 2,600 | 293,593 | 12,139 | 14.7 K to 12.1 K (-17.64 %) |
| Sep 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 13,776 | 15,980 | 14,739 | 963 to 14.7 K (+1,430.53 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 698,000 | |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 100.72 | 1,200 | 120,859 | 963 | 2.2 K to 963 (-55.48 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 99.47 | 8,342 | 829,818 | 2,163 | 10.5 K to 2.2 K (-79.41 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 98.94 | 7,458 | 737,930 | 10,505 | 18 K to 10.5 K (-41.52 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,963 | 963 to 18 K (+1,765.32 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 698,000 | |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 100.72 | 1,200 | 120,859 | 963 | 2.2 K to 963 (-55.48 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 99.47 | 8,342 | 829,818 | 2,163 | 10.5 K to 2.2 K (-79.41 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 98.94 | 7,458 | 737,930 | 10,505 | 18 K to 10.5 K (-41.52 %) |
| Aug 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,963 | 963 to 18 K (+1,765.32 %) |
| Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 715,000 | |
| Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 88.73 | 500 | 44,366 | 0 | 500 to 0 (-100.00 %) |
| Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 87.94 | 8,900 | 782,708 | 500 | 9.4 K to 500 (-94.68 %) |
| Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 87.11 | 7,600 | 662,062 | 9,400 | 17 K to 9.4 K (-44.71 %) |
| Jul 02 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 732,000 | |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 81.92 | 2,000 | 163,844 | 0 | 2 K to 0 (-100.00 %) |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 81.39 | 4,900 | 398,801 | 2,000 | 6.9 K to 2 K (-71.01 %) |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 80.05 | 2,500 | 200,132 | 6,900 | 9.4 K to 6.9 K (-26.60 %) |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 79.14 | 2,500 | 197,845 | 9,400 | 11.9 K to 9.4 K (-21.01 %) |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 78.06 | 3,400 | 265,420 | 11,900 | 15.3 K to 11.9 K (-22.22 %) |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 77.17 | 1,700 | 131,182 | 15,300 | 17 K to 15.3 K (-10.00 %) |
| Jun 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 749,000 | |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 79.23 | 300 | 23,769 | 0 | 300 to 0 (-100.00 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 78.66 | 4,200 | 330,370 | 300 | 4.5 K to 300 (-93.33 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 77.57 | 3,695 | 286,634 | 4,500 | 8.2 K to 4.5 K (-45.09 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 76.63 | 8,805 | 674,696 | 8,195 | 17 K to 8.2 K (-51.79 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 749,000 | |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 79.23 | 300 | 23,769 | 0 | 300 to 0 (-100.00 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 78.66 | 4,200 | 330,370 | 300 | 4.5 K to 300 (-93.33 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 77.57 | 3,695 | 286,634 | 4,500 | 8.2 K to 4.5 K (-45.09 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 76.63 | 8,805 | 674,696 | 8,195 | 17 K to 8.2 K (-51.79 %) |
| May 05 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
| Apr 23 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | A | 74.58 | 90,667 | 6,761,945 | 90,667 | |
| Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 766,000 | |
| Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 59.62 | 400 | 23,848 | 0 | 400 to 0 (-100.00 %) |
| Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 58.33 | 7,789 | 454,318 | 400 | 8.2 K to 400 (-95.12 %) |
| Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 57.75 | 8,811 | 508,840 | 8,189 | 17 K to 8.2 K (-51.83 %) |
| Apr 03 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | M | 1.16 | 17,000 | 19,720 | 783,000 | |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 70.35 | 41 | 2,884 | 0 | 41 to 0 (-100.00 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 69.10 | 5,800 | 400,777 | 41 | 5.8 K to 41 (-99.30 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 68.19 | 546 | 37,230 | 5,841 | 6.4 K to 5.8 K (-8.55 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 66.85 | 600 | 40,112 | 6,387 | 7 K to 6.4 K (-8.59 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 65.71 | 1,200 | 78,855 | 6,987 | 8.2 K to 7 K (-14.66 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 64.78 | 1,513 | 98,009 | 8,187 | 9.7 K to 8.2 K (-15.60 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 63.69 | 5,110 | 325,477 | 9,700 | 14.8 K to 9.7 K (-34.50 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Sell | S | 62.62 | 2,190 | 137,133 | 14,810 | 17 K to 14.8 K (-12.88 %) |
| Mar 09 2020 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Buy | M | 1.16 | 17,000 | 19,720 | 17,000 | 0 to 17 K |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 11.48 | 70,000 | 803,600 | 70,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 11.48 | 70,000 | 803,600 | 0 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 5.04 | 125,000 | 630,000 | 125,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 5.04 | 125,000 | 630,000 | 0 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 1.20 | 25,000 | 30,000 | 25,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 1.20 | 25,000 | 30,000 | 0 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 1.16 | 800,000 | 928,000 | 800,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Chief Commercial Of ... | Option Exercise | J | 1.16 | 800,000 | 928,000 | 0 |
Page: 1